AI
JAZZ icon

Atria Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Atria Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
4,514
+1,350
+43% +$296K 0.01% 1069
2026
Q1 		$598K Sell
3,164
-1,405
-31% -$246K 0.01% 1347
2025
Q4 		$777K Sell
4,569
-275
-6% -$42.2K 0.01% 1206
2025
Q3 		$638K Buy
4,844
+1,556
+47% +$187K 0.01% 1295
2025
Q2 		$349K Buy
3,288
+34
+1% +$3.69K ﹤0.01% 1624
2025
Q1 		$404K Buy
3,254
+522
+19% +$68.1K 0.01% 1467
2024
Q4 		$336K Buy
2,732
+445
+19% +$52.4K ﹤0.01% 1539
2024
Q3 		$255K Sell
2,287
-8
-0.3% -$877 ﹤0.01% 1698
2024
Q2 		$245K Buy
+2,295
New +$252K ﹤0.01% 1706
2020
Q1 		– Sell
-1,419
Closed -$212K – 886
2019
Q4 		$212K Buy
+1,419
New +$193K 0.01% 1129
2019
Q1 		– Sell
-2,743
Closed -$340K – 989
2018
Q4 		$340K Sell
2,743
-587
-18% -$87.1K 0.02% 618
2018
Q3 		$560K Sell
3,330
-446
-12% -$76.7K 0.02% 561
2018
Q2 		$651K Buy
+3,776
New +$617K 0.03% 490
2014
Q4 		– Sell
-1,304
Closed -$209K – 441
2014
Q3 		$209K Buy
+1,304
New +$200K 0.02% 433
2014
Q1 		– Sell
-1,635
Closed -$207K – 446
2013
Q4 		$207K Buy
+1,635
New +$169K 0.02% 429

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Atria Investments's JAZZ Position: Q2 2026 in Review

Atria Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 43% in Q2 2026, buying an estimated $296K and bringing the position to 4,514 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1069.

Atria Investments first reported a position in JAZZ in Q4 2013 and has held it in 15 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Atria Investments held 4,514 shares of Jazz Pharmaceuticals worth $1.09M as of Q2 2026.
  • Atria Investments bought 1,350 Jazz Pharmaceuticals shares in Q2 2026, an estimated $296K.
  • Jazz Pharmaceuticals made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1069 holding.
  • Atria Investments first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 15 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.